FDA Removes Clinical Hold On Inovio Pharma's VGX-3100, Its First Drug To Enter A Pivotal Study
June 08, 2017 at 10:56 AM EDT
Inovio Pharmaceuticals Inc (NASDAQ: INO) announced Thursday morning it has commenced a Phase III clinical program (called REVEAL) to ...